← Back

Wire · opportunities

Science Corporation’s brain tech is worth $3.5 billion after new funding

Published

17 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at techcrunch.com →

◆ Verified

Fusion42 · 17 November 2026 · Fusion42 review

Science Corporation raised $400 million in Series D funding, valuing the company at $3.5 billion. The startup develops a wearable and implantable chip to restore vision for age-related macular degeneration and plans to seek FDA approval to expand use in the US, while also preparing trials for brain-related treatments.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Your Medtech startup should track Science Corporation’s FDA approach as it opens US access to rare-condition vision tech, setting a precedent for similar brain-implant devices. This funding jump signals growing investor confidence and a clearer path to clinical trials for neurotech treatments.

◆ Coverage

1 source · 17 Nov 2026

◆ Related on Wire

◆ Topics

Medtechbrain-techmedtechfundingvision-restorationFDA-approval